etylMobility is a powerful new product for Fibromyalgia, Lupus, and Arthritis sufferers, and is showing tremendous results in alleviating the muscle and joint pain of these conditions. Introduced by Neways, International on October 18, 1999, it was formulated after "researching the research" already performed for these conditions, and improving upon the results. CetylMobility has been laboratory tested for safety and clinically proven to be effective. Neways is the largest alternative health product manufacturer in the world today, distributing products in 40 countries worldwide.